In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against the other stocks in Cathie Wood's portfolio. Cathie Wood is one of Wall Street's most ...
1d
News Medical on MSNPioneering the world’s first CRISPR medicine for sickle cell diseaseWhen Vijay Sankaran was an MD-PhD student at Harvard Medical School in the mid-2000s, one of his first clinical encounters ...
CRISPR Therapeutics AG ( NASDAQ: CRSP) TD Cowen 45th Annual Healthcare Conference March 3, 2025 10:30 AM ET ...
CRISPR Therapeutics is the gene-editing specialist ... Cathie Wood is one of Wall Street’s most contentious figures. She founded ARK Investment Management around ten […] Amgen, CRISPR, Moderna ...
It's likely that 2024 as a whole will represent something of a lull in CRISPR's history. In its earnings ... has positions in and recommends CRISPR Therapeutics and Vertex Pharmaceuticals.
A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...
In terms of liquidity and interest, the mean open interest for CRISPR Therapeutics options trades today is 628.14 with a total volume of 1,152.00.
Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options become available today, for the April 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
Shares of NASDAQ:CRSP opened at $52.29 on Tuesday. CRISPR Therapeutics has a 52-week low of $36.52 and a 52-week high of $91.10. The stock has a market cap of $4.46 billion, a price-to-earnings ...
A Phase III trial evaluating nex-z in transthyretin amyloidosis with cardiomyopathy is underway, with plans for another ...
CRISPR Therapeutics is the gene-editing specialist ... Cathie Wood is one of Wall Street’s most contentious figures. She founded ARK Investment Management around ten […] Amgen, CRISPR, Moderna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results